Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · February 19, 2024

Hypouricemia as a Novel Predictor of Mortality in Anti-MDA5–Positive Dermatomyositis Patients With ILD

Respiratory Medicine


Additional Info

Respiratory Medicine
Hypouricemia as a novel predictor of mortality in anti-MDA5 positive dermatomyositis patients with ILD: A retrospective cohort study
Respir Med 2024 Feb 01;222(xx)107530, H Liu, B Chen, Y Guo, H Liu, J Ran, R Liu, G Yin, Q Xie

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading